Open AccessIn Reply to the Discovery Trial Report Evaluating the Potential Benefit of Hydroxychloroquine, Lopinavir and Ritonavir with and Without Interferon Β-1a in Hospitalized Covid-19 Patients
Author(s) -
Valère Lounnas,
Xavier Azalbert,
Christian Perronne
Publication year - 2021
Publication title -
archives of microbiology and immunology
Language(s) - English
Resource type - Journals
ISSN - 2572-9365
DOI - 10.26502/ami.93650064
Subject(s) - lopinavir , hydroxychloroquine , lopinavir/ritonavir , ritonavir , covid-19 , medicine , virology , interferon , intensive care medicine , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , disease , outbreak , infectious disease (medical specialty)